Correlation Between Ocular Therapeutix and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ocular Therapeutix and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocular Therapeutix and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocular Therapeutix and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Ocular Therapeutix and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocular Therapeutix with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocular Therapeutix and Achilles Therapeutics.
Diversification Opportunities for Ocular Therapeutix and Achilles Therapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Ocular and Achilles is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Ocular Therapeutix and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Ocular Therapeutix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocular Therapeutix are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Ocular Therapeutix i.e., Ocular Therapeutix and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Ocular Therapeutix and Achilles Therapeutics
Given the investment horizon of 90 days Ocular Therapeutix is expected to under-perform the Achilles Therapeutics. In addition to that, Ocular Therapeutix is 1.73 times more volatile than Achilles Therapeutics PLC. It trades about -0.27 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about -0.03 per unit of volatility. If you would invest 114.00 in Achilles Therapeutics PLC on November 3, 2024 and sell it today you would lose (1.00) from holding Achilles Therapeutics PLC or give up 0.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Ocular Therapeutix vs. Achilles Therapeutics PLC
Performance |
| Timeline |
| Ocular Therapeutix |
| Achilles Therapeutics PLC |
Ocular Therapeutix and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ocular Therapeutix and Achilles Therapeutics
The main advantage of trading using opposite Ocular Therapeutix and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocular Therapeutix position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.| Ocular Therapeutix vs. CytomX Therapeutics | Ocular Therapeutix vs. Assembly Biosciences | Ocular Therapeutix vs. Spero Therapeutics | Ocular Therapeutix vs. Achilles Therapeutics PLC |
| Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |